Drug Profile
Fentanyl transdermal
Alternative Names: MatrifenLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Nycomed
- Developer Takeda
- Class Amides; Benzene derivatives; General anaesthetics; Opioid analgesics; Piperidines; Small molecules
- Mechanism of Action Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Pain
Most Recent Events
- 29 Mar 2012 Nycomed is now called Takeda Pharmaceuticals International
- 30 Sep 2011 Launched for Pain in South Korea (Transdermal)
- 30 Sep 2011 Nycomed has been acquired by Takeda